The synthesis of [36Cl]-, [82Br]- and [123I]-labelled 1-(3'-chloro-(bromo and iodo)-3'-deoxy-beta-D-arabinofuranosyl)uracil.
Reaction of the epoxy nucleoside 1-(2',3'-epoxy-beta-D-lyxofuranosyl)uracil (1) with [36Cl]HCl afforded [36Cl]-1-(3'-chloro-3'-deoxy-beta-D-arabinofuranosyl)uracil (2a) with a specific activity of 5.48 MBq mmol-1. A similar reaction of 1 with [82Br]NH4Br yielded [82Br]-1-(3'-bromo-3'-deoxy-beta-D-arabinofuranosyl)uracil (2b) with a specific activity of 29 MBq mmol-1. Alternatively neutron activation of the preformed [81Br]-1-(3'-bromo-3'-deoxy-beta-D-arabinofuranosyl)uracil (2b) gave low yields of the [82Br)-labelled 2b with a specific activity of 8.99 MBq mmol-1. [123I]-1-(3'-Iodo-3'-deoxy-beta-D-arabinofuranosyl)uracil (2c) was similarly prepared with a specific activity of 125 GBq mmol-1 by the reaction of [123I]HI with the epoxide. These compounds were prepared for evaluation as non-invasive tumor imaging radiopharmaceuticals.